Cargando…
Assessing the Impact of Intensified Hypertension (HTN) Treatment Guidelines: A Single Center Experience
Introduction: Hypertension (HTN) is an independent risk factor for heart disease, stroke, and premature death. In 2017 there was a shift in the definition of HTN by the American College of Cardiology (ACC), as well as the American Heart Association (ACC/AHA), resulting in lower blood pressure (BP) r...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9851089/ https://www.ncbi.nlm.nih.gov/pubmed/36686098 http://dx.doi.org/10.7759/cureus.32734 |
_version_ | 1784872334480375808 |
---|---|
author | Naqvi, Amir Zughaib, Marc T Freeman, David Gupta, Tanuj Leung, Emmanuel Zughaib, Marcel E |
author_facet | Naqvi, Amir Zughaib, Marc T Freeman, David Gupta, Tanuj Leung, Emmanuel Zughaib, Marcel E |
author_sort | Naqvi, Amir |
collection | PubMed |
description | Introduction: Hypertension (HTN) is an independent risk factor for heart disease, stroke, and premature death. In 2017 there was a shift in the definition of HTN by the American College of Cardiology (ACC), as well as the American Heart Association (ACC/AHA), resulting in lower blood pressure (BP) readings meeting criteria for diagnosis. Our study aimed to explore the impact the change had on a single cardiology practice’s management of patients with HTN. Methods: We performed a retrospective chart review of a single cardiology practice. We separated the time into two categories: 12 months before and 12 months after the reclassification of HTN categories in November 2017. A paired t-test analysis was done comparing averaged blood pressures (BPs) in each of the two time periods, as well as the number of medications in each time period and several subgroup analyses. Results: A total of 441 patients were included in the final analysis. Patients were prescribed an average of 2.61 ± 1.20 medications at baseline, and 2.74 ± 1.22 medications post-reclassification (p < 0.0001). There was an average of 0.82 ± 1.28 medication changes per patient. The overall average BP was 133.7 ± 14.1/76.4 ± 9.5 at baseline, and 131.3 ± 13.1/76.7 ± 7.7 after the recategorization [Δ -2.41 (95% CI 1.18-3.63)/0.269 (95% CI -0.29 to 0.459); p<0.0001 for systolic blood pressure (SBP), p=0.467 for diastolic blood pressure (DBP)]. Conclusion: The change in definition of HTN significantly impacted this single cardiology practice. There was a statistically significant increase in antihypertensive medications prescribed with an expected decrease in BP observed in this study. |
format | Online Article Text |
id | pubmed-9851089 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-98510892023-01-19 Assessing the Impact of Intensified Hypertension (HTN) Treatment Guidelines: A Single Center Experience Naqvi, Amir Zughaib, Marc T Freeman, David Gupta, Tanuj Leung, Emmanuel Zughaib, Marcel E Cureus Cardiology Introduction: Hypertension (HTN) is an independent risk factor for heart disease, stroke, and premature death. In 2017 there was a shift in the definition of HTN by the American College of Cardiology (ACC), as well as the American Heart Association (ACC/AHA), resulting in lower blood pressure (BP) readings meeting criteria for diagnosis. Our study aimed to explore the impact the change had on a single cardiology practice’s management of patients with HTN. Methods: We performed a retrospective chart review of a single cardiology practice. We separated the time into two categories: 12 months before and 12 months after the reclassification of HTN categories in November 2017. A paired t-test analysis was done comparing averaged blood pressures (BPs) in each of the two time periods, as well as the number of medications in each time period and several subgroup analyses. Results: A total of 441 patients were included in the final analysis. Patients were prescribed an average of 2.61 ± 1.20 medications at baseline, and 2.74 ± 1.22 medications post-reclassification (p < 0.0001). There was an average of 0.82 ± 1.28 medication changes per patient. The overall average BP was 133.7 ± 14.1/76.4 ± 9.5 at baseline, and 131.3 ± 13.1/76.7 ± 7.7 after the recategorization [Δ -2.41 (95% CI 1.18-3.63)/0.269 (95% CI -0.29 to 0.459); p<0.0001 for systolic blood pressure (SBP), p=0.467 for diastolic blood pressure (DBP)]. Conclusion: The change in definition of HTN significantly impacted this single cardiology practice. There was a statistically significant increase in antihypertensive medications prescribed with an expected decrease in BP observed in this study. Cureus 2022-12-20 /pmc/articles/PMC9851089/ /pubmed/36686098 http://dx.doi.org/10.7759/cureus.32734 Text en Copyright © 2022, Naqvi et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Cardiology Naqvi, Amir Zughaib, Marc T Freeman, David Gupta, Tanuj Leung, Emmanuel Zughaib, Marcel E Assessing the Impact of Intensified Hypertension (HTN) Treatment Guidelines: A Single Center Experience |
title | Assessing the Impact of Intensified Hypertension (HTN) Treatment Guidelines: A Single Center Experience |
title_full | Assessing the Impact of Intensified Hypertension (HTN) Treatment Guidelines: A Single Center Experience |
title_fullStr | Assessing the Impact of Intensified Hypertension (HTN) Treatment Guidelines: A Single Center Experience |
title_full_unstemmed | Assessing the Impact of Intensified Hypertension (HTN) Treatment Guidelines: A Single Center Experience |
title_short | Assessing the Impact of Intensified Hypertension (HTN) Treatment Guidelines: A Single Center Experience |
title_sort | assessing the impact of intensified hypertension (htn) treatment guidelines: a single center experience |
topic | Cardiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9851089/ https://www.ncbi.nlm.nih.gov/pubmed/36686098 http://dx.doi.org/10.7759/cureus.32734 |
work_keys_str_mv | AT naqviamir assessingtheimpactofintensifiedhypertensionhtntreatmentguidelinesasinglecenterexperience AT zughaibmarct assessingtheimpactofintensifiedhypertensionhtntreatmentguidelinesasinglecenterexperience AT freemandavid assessingtheimpactofintensifiedhypertensionhtntreatmentguidelinesasinglecenterexperience AT guptatanuj assessingtheimpactofintensifiedhypertensionhtntreatmentguidelinesasinglecenterexperience AT leungemmanuel assessingtheimpactofintensifiedhypertensionhtntreatmentguidelinesasinglecenterexperience AT zughaibmarcele assessingtheimpactofintensifiedhypertensionhtntreatmentguidelinesasinglecenterexperience |